药品注册申请号:012806
申请类型:NDA (新药申请)
申请人:ALMIRALL
申请人全名:ALMIRALL LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CORDRAN FLURANDRENOLIDE OINTMENT;TOPICAL 0.05% Yes No AT 1965/10/18 Approved Prior to Jan 1, 1982 Discontinued
002 CORDRAN SP FLURANDRENOLIDE CREAM;TOPICAL 0.05% Yes No None Approved Prior to Jan 1, 1982 Discontinued
003 CORDRAN SP FLURANDRENOLIDE CREAM;TOPICAL 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
004 CORDRAN FLURANDRENOLIDE OINTMENT;TOPICAL 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None Approved Prior to Jan 1, 1982 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2013/07/23 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
2013/06/12 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
2012/12/14 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
2008/03/25 SUPPL-32(补充) Approval Manufacturing (CMC) N/A
2002/07/17 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1998/11/06 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1991/08/30 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1990/10/02 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1987/12/18 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1987/06/03 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1986/11/14 SUPPL-22(补充) Approval Labeling
1982/10/08 SUPPL-21(补充) Approval Labeling
1980/08/12 SUPPL-20(补充) Approval Labeling
1979/11/26 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1978/07/24 SUPPL-16(补充) Approval Labeling
1978/06/30 SUPPL-17(补充) Approval Labeling
1977/12/14 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1977/11/11 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1977/02/23 SUPPL-14(补充) Approval Labeling
1965/10/18 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:FLURANDRENOLIDE 剂型/给药途径:OINTMENT;TOPICAL 规格:0.05% 治疗等效代码:AT
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
012806 001 NDA CORDRAN FLURANDRENOLIDE OINTMENT;TOPICAL 0.05% Discontinued Yes No AT Approved Prior to Jan 1, 1982 ALMIRALL
207851 001 ANDA FLURANDRENOLIDE FLURANDRENOLIDE OINTMENT;TOPICAL 0.05% Prescription No Yes AT 2016/12/30 TELIGENT
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database